Cytokeratin 20: A marker for diagnosing Merkel cell carcinoma

被引:106
作者
Scott, MP [1 ]
Helm, KF [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Med Dermatol & Pathol, Coll Med, Hershey, PA 17033 USA
关键词
cytokeratin; 20; Merkel cell carcinoma;
D O I
10.1097/00000372-199902000-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Merkel cell carcinoma is an aggressive cutaneous neoplasm that is often difficult to diagnose because of its histologic and immunohistochemical similarity to metastatic oat cell carcinomas and other cutaneous neoplasms. Our purpose was to determine the utility of immunoperoxidase staining of cytokeratin 20 (CK 20) a newly discovered intermediate filament protein, in Merkel cell carcinomas and other cutaneous tumors. Sixty-one tumors were sectioned and stained with antibodies directed at CK 20. The staining of Merkel cell carcinomas was compared with metastatic oat cell carcinomas, lymphomas, squamous cell carcinomas, basal cell carcinomas, melanomas, metastatic carcinoids. spiradenomas, eccrine carcinomas, adenoidcystic carcinoma, sebaceous carcinomas, hidradenomas, sebaceous epitheliomas. trichoblastomas, mixed tumors, and metastatic adenocarcinomas. Nine of 10 Merkel cell carcinomas stained with antibody to CK 20. Two metastatic carcinomas to the skin were also positive. One hidradenoma and one squamous carcinoma exhibited focal staining, but were otherwise negative. All other turners were nonstaining. Cytokeratin 20 is a sensitive and specific marker for Merkel cell carcinoma and is helpful in distinguishing between Merkel cell carcinoma and other malignant and benign neoplasms.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 46 条
[1]  
BARYOU O, 1991, J AM ACAD DERMATOL, V24, P198
[2]  
BATTIFORA H, 1986, CANCER, V58, P1040, DOI 10.1002/1097-0142(19860901)58:5<1040::AID-CNCR2820580511>3.0.CO
[3]  
2-L
[4]  
BRINKSCHMIDT C, 1995, APPL IMMUNOHISTO M M, V3, P37
[5]   ADENOCARCINOMA OF THE LUNG - IMMUNOHISTOCHEMICAL FINDINGS (KERATIN CEA) [J].
BROCKMANN, M ;
BROCKMANN, I ;
HERBERG, U ;
MULLER, KM .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1987, 113 (04) :379-382
[6]   Cytokeratin 20 immunoreactivity distinguishes merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites [J].
Chan, JKC ;
Suster, S ;
Wenig, BM ;
Tsang, WYW ;
Chan, JBK ;
Lau, ALW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (02) :226-234
[7]  
GOEPFERT H, 1984, ARCH OTOLARYNGOL, V110, P238
[8]  
GOULD VE, 1987, AM J PATHOL, V126, P243
[9]  
GOULD VE, 1985, LAB INVEST, V52, P334
[10]   DISSEMINATED MERKEL CELL TUMOR - TREATMENT WITH SYSTEMIC CHEMOTHERAPY [J].
GROSH, WW ;
GIANNONE, L ;
HANDE, KR ;
JOHNSON, DH .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03) :227-230